Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional approval filing for Hydronidone and priority review ...
The Relics you will need to farm for Gyre Prime are the Lith G14, Meso V14, Neo T10, Axi T13. Finding them will allow you to farm the following parts: Quick Relic farming is vital to getting ...
Fintel reports that on October 10, 2025, Jefferies initiated coverage of Gyre Therapeutics (NasdaqCM:GYRE) with a Buy recommendation. Analyst Price Forecast Suggests 171.05% Upside As of September 30, ...
Tesla on Tuesday unveiled plans to sell cheaper alternatives of its Model Y and Model 3 cars, its first product release in years, as Elon Musk’s automaker created more affordable options for its ...
Tesla has unveiled the long-promised cheaper versions of its two main cars, dubbed the Model 3 Standard and Model Y Standard, after the expiration of the $7,500 tax credit for American buyers of most ...
An analysis of clam shells suggests the North Atlantic subpolar gyre has had two periods of destabilization over the past 150 years: one around 1920 and the other from 1950 through present. When you ...
Base Model Y isn’t as cheap as we’d hoped, and several rivals are still more affordable. Remember Tesla’s $25,000 budget EV? Neither do we, since it was scrapped before it ever reached production. But ...
Hosted on MSN
Gyre Therapeutics Announces Positive Phase 3 Results
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Gyre Therapeutics ( (GYRE)) has provided ...
The global biopharmaceutical landscape is rapidly evolving, driven by innovations targeting complex diseases like organ fibrosis and liver conditions. As companies push the boundaries of medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback